NCOA2 and neoplasm: In the first case, speculation about the misdiagnosis of the initial tumor could be justified (even the report’s title uses of confusing terminology); however, the latter case is substantiated by meticulous molecular analysis showing a UTROSCT-typical genetic rearrangement in the recurrent tumor (GREB1-NCOA2 fusion) [110].